Ted Harada, diagnosed with the disease in 2010, has been a walking advertisement for their treatment after two surgeries that he underwent as part of the Phase 1 clinical trials at Emory University.
http://www.forbes.com/sites/johnfarrell/2013/11/21/a-closer-look-at-neuralstems-als-treatment/
http://www.forbes.com/sites/johnfarrell/2013/11/21/a-closer-look-at-neuralstems-als-treatment/
No comments:
Post a Comment